NCT01196884UnknownNot Applicable
IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT
Azienda Sanitaria-Universitaria Integrata di Udine13 sites in 1 country190 target enrollmentStarted: September 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 190
- Locations
- 13
Study Overview
Brief Summary
Primary ITP has wide heterogenous biology, presentation and response to therapy.
The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Adult patients with primary ITP
Exclusion Criteria
- •Secondary ITP
Investigators
Study Sites (13)
Loading locations...
Similar Trials
Unknown
Not Applicable
Investigation on a Dynamic Cohort of Italian Patients With Active ITPIdiopathic Thrombocytopenic PurpuraNCT03465020Gruppo Italiano Malattie EMatologiche dell'Adulto861
Recruiting
Not Applicable
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)Primary Immune ThrombocytopeniaNCT06107582Institute of Hematology & Blood Diseases Hospital, China500
Completed
Not Applicable
Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICFPrimary Immune DeficiencyExercise CapacityPhysical ActivityQuality of LifeNCT06014463Hacettepe University40
Completed
Not Applicable
Genetic and Immunologic Characterization of IEIImmunity DisordersInborn Errors of ImmunityNCT05803356IRCCS Burlo Garofolo156
Recruiting
Phase 3
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)NCT05338190Assistance Publique - Hôpitaux de Paris132